BCG Vaccine Market OverviewBacillus Calmette–Guerin (BCG) vaccine is usually given to newborn babies. Vaccination can be done from 6 months old to five years of age. According to World Health Organization, the annual risk of TB infection in children in high-burden countries is estimated to be 0.5-2%. Hence, BCG vaccines played an important role to protect newborns from tuberculosis and other similar diseases. This crucial factor is highly contributed to the growth of the global BCG vaccines market in the last few years.
Furthermore, increasing advancements in the vaccination camps. Also, solid campaigns in online and offline mode providing information to common people about proper vaccination in the current time. This important factor is expected to fuel the growth of the market. Also, the growing incidence of tuberculosis across the world and the rise in research activities for the development of the BCG vaccine are enhancing the market growth.
On the other hand, side effects and a global shortage of BCG vaccines may hamper the growth of the market. Besides, favorable government initiatives and a good focus on the vaccination programs globally are expected to open new opportunities for leading vendors of BCG vaccines in the forthcoming years.
BCG Vaccine Market Segment OverviewThe immune BCG segment holds the highest share in the market. This is on account of the major role of BCG in effectively helping TB prevention and as of now, there is no substitute vaccine for immune BCG. In addition, several new vendors are focusing on developing new vaccinations for bladder cancer is anticipated to boost the market growth in the coming years.
BCG Vaccine Market Regional OverviewThe market of the Asia Pacific is expected to grow at the fastest rate over the forecasted period. This is due to the high demand for BCG vaccines for the prevention of tuberculosis in the region. For instance, The Government of India has announced its plan to eliminate TB by 2025 during the Union Budget 2017–2018. Additionally, the market in Latin America and the Middle East, and Africa is expected to show noteworthy growth due to increasing awareness about the BCG vaccines.
BCG Vaccine Market Competitor overview· In April 2020, the Serum Institute of India launched human trials to test the new BCG vaccine that can boost immunity in the fight against Covid-19.
BCG Vaccine Market, Key Players· Intervax Ltd
· Greensignal Bio Pharma Limited
· AJ Vaccines
· China National Pharmaceutical Group Corporation
· Japan BCG Laboratory
· Greensignal Bio Pharma Limited
· Serum Institute of India Pvt. Ltd.
· Merck & Company Inc
· Sanofi S.A.
· Statens Serum Institute
· Gsbpl C
· Shanghai Institute of Biological Products
· Japan BCG Laboratory
BCG Vaccine Market SegmentationBCG Vaccine Market, By Drug Type
· Immune BCG
· Therapy BCG
BCG Vaccine Market, By Usage
· Tuberculosis
· Bladder Cancer
BCG Vaccine Market, By End User
· Pediatrics
· Adults
BCG Vaccine market, By Region
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
List of Figures
Figure 1: Global BCG Vaccine Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global BCG Vaccine Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America BCG Vaccine Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America BCG Vaccine Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America BCG Vaccine Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America BCG Vaccine Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America BCG Vaccine Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe BCG Vaccine Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe BCG Vaccine Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe BCG Vaccine Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe BCG Vaccine Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe BCG Vaccine Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe BCG Vaccine Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe BCG Vaccine Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Research Process
Data Library Research are conducted by industry experts who offer insight on
industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager
and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary Research
Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
